Ombitasvir is an antiviral agent and NS5A inhibitor used in combination therapy to treat chronic hepatitis C virus (HCV) infection by blocking the viral NS5A protein. To support the rigorous demands of… Read more









Ombitasvir is an antiviral agent and NS5A inhibitor used in combination therapy to treat chronic hepatitis C virus (HCV) infection by blocking the viral NS5A protein. To support the rigorous demands of pharmaceutical analysis, this category provides a comprehensive selection of Ombitasvir reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites. These materials are essential for pharmaceutical laboratories conducting impurity profiling and method validation, ensuring accurate identification and quantification of impurities in drug substance and drug product batches. Additionally, stable isotope labelled compounds are available to serve as internal standards for sensitive mass spectrometry-based assays. By utilizing these high-quality materials, researchers and quality control professionals can reliably monitor product integrity, support regulatory compliance, and maintain the standards required for the development and testing of complex antiviral therapeutic regimens.